Iohexagita

Iohexol, the active ingredient in Iohexagita, is an iodinated contrast agent presented as a sterile injectable solution for intravenous or intra‑arterial use. It enhances radiographic visibility of vascular structures and organs during diagnostic imaging procedures. GNH USA supplies Iohexagita as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, imaging centres and clinics worldwide.

Iohexagita is used as an iodinated contrast medium in various diagnostic imaging procedures. - Computed Tomography (CT): improves visualization of soft tissues, vessels and organs. - Angiography: delineates arterial and venous anatomy for cardiovascular assessment. - Intravenous urography: enhances detection of urinary tract abnormalities. - Arthrography: provides contrast for joint space evaluation. - Myelography: outlines spinal canal and nerve roots for neurological imaging.

Adverse reactions to Iohexagita may range from mild to severe and are reported following administration of iodinated contrast agents.

Common Side Effects: - Warmth or flushing sensation at injection site. - Metallic taste in the mouth. - Nausea or vomiting. - Headache or dizziness. - Mild urticaria or itching. - Transient increase in blood pressure.

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction. - Acute renal failure, especially in patients with pre‑existing kidney disease. - Cardiac arrhythmias or hypotension. - Seizures or neurologic disturbances. - Pulmonary edema. - Persistent skin rash or Stevens‑Johnson syndrome.

When using Iohexagita, clinicians should assess patient history and monitor for potential complications. - Renal function: evaluate creatinine clearance before administration. - Allergy history: screen for prior reactions to iodinated contrast. - Thyroid disease: consider risk of iodine‑induced thyroid dysfunction. - Diabetes: suspend metformin in at‑risk patients per guidelines. - Hydration: ensure adequate fluid intake to reduce nephrotoxicity. Store below 25°C: keep in original container, protect from light and moisture.

Iohexagita may interact with other medications, influencing safety or efficacy.

Major Interactions (Avoid): - Metformin: risk of lactic acidosis in renal impairment; discontinue before contrast. - Thyroid hormone preparations: excess iodine may alter thyroid function. - Radioactive iodine therapy: iodine load can interfere with treatment efficacy.

Moderate Interactions (Monitor Closely): - NSAIDs and diuretics: may increase risk of contrast‑induced nephropathy. - ACE inhibitors or ARBs: monitor renal function and blood pressure. - Beta‑blockers: may mask tachycardia associated with allergic reactions.